Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer

The current strategy for diagnosing prostate cancer (PCa) is mainly based on the serum prostate-specific antigen (PSA) test. However, PSA has low specificity and has led to numerous unnecessary biopsies. We evaluated the effectiveness of urinary metastasis-associated lung adenocarcinoma transcript 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fubo, Ren, Shancheng, Chen, Rui, Lu, Ji, Shi, Xiaolei, Zhu, Yasheng, Zhang, Wei, Jing, Taile, Zhang, Chao, Shen, Jian, Xu, Chuanliang, Wang, Huiqing, Wang, Haifeng, Wang, Yang, Liu, Bin, Li, Yaoming, Fang, Ziyu, Guo, Fei, Qiao, Meng, Wu, Chengyao, Wei, Qiang, Xu, Danfeng, Shen, Dan, Lu, Xin, Gao, Xu, Hou, Jianguo, Sun, Yinghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294360/
https://www.ncbi.nlm.nih.gov/pubmed/25526029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294360/
https://www.ncbi.nlm.nih.gov/pubmed/25526029

Ejemplares similares